Skip to main content
Kevin High, MD, Infectious Disease, Winston Salem, NC

Kevin High MD MS; FACP, FIDSA

Transplant/Immunocompromised States


Professor of Medicine and Translational Science, Wake Forest School of Medicine; Chief, Section on Infectious Diseases

Join to View Full Profile
  • S Hawthorne RdWinston Salem, NC 27157

  • Phone+1 336-716-2255

Dr. High is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Wake Forest University
    Wake Forest UniversityM.Sc., Epidemiology, 1998
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Infectious Disease, 1990 - 1993
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Internal Medicine, 1986 - 1990
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1986
  • Bucknell University
    Bucknell UniversityB.S., Biology, Magna Cum Laude, 1982

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1993 - 2026
  • VA State Medical License
    VA State Medical License 1988 - 2008
  • CT State Medical License
    CT State Medical License 1990 - 1994
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Special Recognition Award Alliance for Academic Internal Medicine, 2013
  • Reidar Wallin Faculty Teaching Award MMTS Program, 2012
  • Laureate Award NC Chapter ACP, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Preserving Elective Surgeries in the COVID-19 Pandemic and the Future  
    Kevin High, MD, JAMA
  • CMX-001 to prevent cytomegalovirus disease in hematopoietic cell transplantation  
    Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Mommeja-Marin H, Boeckh M; CMX001-201 Clinical Study Group ..., Engl J Med, 1/1/2013
  • Fidaxomicin versus Vancomycin for Infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial  
    Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, Sears P, Gorbach S; OPT-80-004 Clinical Study Group (High, KP), Lancet Infect Dis, 1/1/2012
  • Join now to see all

Other

Press Mentions

  • Atrium Health, Wake Forest University School of Medicine Receive PCORI Funding to Enhance Cancer Patient Care Through Advanced Symptom Tracking
    Atrium Health, Wake Forest University School of Medicine Receive PCORI Funding to Enhance Cancer Patient Care Through Advanced Symptom TrackingMay 8th, 2025
  • Atrium Health Named to 2021 Joy in Medicine™ Health System Recognition Program
    Atrium Health Named to 2021 Joy in Medicine™ Health System Recognition ProgramOctober 8th, 2021
  • Wake Forest Baptist Health Relaxes Visitor Restrictions, Letting More Visitors See Patients
    Wake Forest Baptist Health Relaxes Visitor Restrictions, Letting More Visitors See PatientsJune 9th, 2021
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: